Low-Dose vs. High-Dose Cisplatin: Lessons Learned From 59 Chemoradiotherapy Trials in Head and Neck Cancer

Low-Dose vs. High-Dose Cisplatin: Lessons Learned From 59 Chemoradiotherapy Trials in Head and Neck Cancer

In locally advanced squamous cell carcinomas of the head and neck (LA-SCCHN), concurrent chemoradiotherapy is an integral part of multimodality management both in the adjuvant and in the definitive settings. Although de-intensification strategies have been propelled to the forefront of clinical rese...

Full description

Bibliographic Details
Main Authors: Petr Szturz, Kristien Wouters, Naomi Kiyota, Makoto Tahara, Kumar Prabhash, Vanita Noronha, David Adelstein, Dirk Van Gestel, Jan B. Vermorken
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-02-01
Series:Frontiers in Oncology
Subjects:
head and neck cancer
chemoradiotherapy
fractionation
cisplatin
clinical trials
cumulative dose
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2019.00086/full

Internet

https://www.frontiersin.org/article/10.3389/fonc.2019.00086/full

Similar Items